SILVERARC CAPITAL MANAGEMENT, LLC
Top Portfolio Positions
65 positions ·
$848,929,503 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
2,876,407 | $57,902,072 | 6.82% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
654,746 | $54,946,284 | 6.47% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
1,314,189 | $50,583,134 | 5.96% | |
| CELC |
Celcuity Inc.
Healthcare
|
357,903 | $40,851,048 | 4.81% | |
| IMNM |
Immunome Inc.
Healthcare
|
1,850,278 | $40,465,579 | 4.77% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
991,930 | $37,812,371 | 4.45% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
354,914 | $36,360,939 | 4.28% | |
| ABVX |
Abivax S.A.
Healthcare
|
302,530 | $33,686,715 | 3.97% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
2,002,040 | $32,933,558 | 3.88% | |
| ERAS |
Erasca, Inc.
Healthcare
|
1,851,812 | $29,962,318 | 3.53% |
Portfolio Trend
22 quarters · across all stocks
Holdings in ABVX
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,686,715 | 302,530 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $56,934,837 | 422,193 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $45,820,869 | 539,704 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $1,318,131 | 210,901 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,087,078 | 285,120 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,318,323 | 461,660 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,025,676 | 455,800 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,072,500 | 75,000 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||